Galapagos NV ($GLPG) is a Biotechnology company in the Healthcare sector. The company released news this evening, stating that Gilead has entered into an agreement with the company, and in turn increasing their stake in GLPG from 12.3% to 22% (Marketwatch). This is an incredibly positive news catalyst, as the company is set to receive $5.1 billion as part of the agreement. I expect some profit-taking after the morning run-up, and plan to dip buy this around mid-day at the $144.50 natural resistance level!